CID 135430955

Uk-371800

Structural Information

Molecular Formula
C23H33N7O5S
SMILES
CCC1=C2C(=NN1C)C(=O)NC(=N2)C3=C(N=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)O[C@H](C)COC
InChI
InChI=1S/C23H33N7O5S/c1-6-18-19-20(27-28(18)4)22(31)26-21(25-19)17-12-16(13-24-23(17)35-15(3)14-34-5)36(32,33)30-10-8-29(7-2)9-11-30/h12-13,15H,6-11,14H2,1-5H3,(H,25,26,31)/t15-/m1/s1
InChIKey
WKISNFXGTYNPOO-OAHLLOKOSA-N
Compound name
3-ethyl-5-[5-(4-ethylpiperazin-1-yl)sulfonyl-2-[(2R)-1-methoxypropan-2-yl]oxypyridin-3-yl]-2-methyl-6H-pyrazolo[4,3-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

557
Patents

519.2264 Da
Monoisotopic Mass

0.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 520.23368 223.5
[M+Na]+ 542.21562 235.3
[M+NH4]+ 537.26022 224.7
[M+K]+ 558.18956 231.6
[M-H]- 518.21912 222.9
[M+Na-2H]- 540.20107 226.1
[M]+ 519.22585 225.1
[M]- 519.22695 225.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe